新青年麻醉论坛

 找回密码
 会员注册

QQ登录

只需一步,快速开始

快捷登录

搜索
热搜: 麻醉 视频 中级
查看: 12612|回复: 22
打印 上一主题 下一主题

欧洲麻醉界曝大型丑闻:伪造的科研成果成英国麻醉医师指南?

[复制链接]
跳转到指定楼层
1#
发表于 2011-3-5 20:30:04 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
本帖最后由 华西小卒 于 2011-3-6 09:05 编辑

伪造的科研成果成英国麻醉医师指南?
欧洲曝大型医疗丑闻,数百万病人被使用或致肾衰竭的药物

2011年3月5日     成都商报电子版
  据《每日电讯报》3月3日消息,德国一名顶级麻醉医师伪造研究数据,他的研究成果被应用于英国麻醉医师医学指南,导致数百万接受外科手术的病人被使用有争议的药物。目前,警方已经对该麻醉医师展开犯罪调查。

  57岁的约阿希姆·博尔特供职于德国路德维希港医院,被认为是静脉注射药物研究方面的专家,他的研究成果广泛地刊登在欧洲各大医学刊物上。现在他由于伪造研究数据嫌疑,已经被医院解雇。

  据了解,约阿希姆是羟乙基淀粉注射液的极力推崇者,但他涉嫌从10年前开始收取羟乙基淀粉生产商的赞助。在英国麻醉医师医学指南上,该药物被用于外科手术中促进病人血容量。但最近研究表明,羟乙基淀粉氯化钠注射液用于外科手术中可能导致肾衰竭,失血过多,心脏衰竭等问题而增加死亡风险。该药物目前已经被取消使用。

  这次事件是继去年安德鲁·维克菲尔德医生伪造“麻疹疫苗导致孤独症”研究数据丑闻后的又一大医学丑闻。(国际台)
楼主热帖

马上注册,享用更多功能,让你轻松玩转论坛

您需要 登录 才可以下载或查看,没有帐号?会员注册

x

 友情提示:论坛资源下载与分享的详细说明  (←点击查看详情

2#
发表于 2011-3-5 20:49:46 | 只看该作者
麻醉中是否还适用?

活动公告:做任务得积分和权限(新手奖励计划) (←点击查看详情)

回复 支持 反对

使用道具 举报/纠错

3#
发表于 2011-3-5 20:58:42 | 只看该作者
羟乙基淀粉?D-130?很常用的胶体啊,到底还能不能继续用呢

友情提示:转载请注意注明作者和出处!!

回复 支持 反对

使用道具 举报/纠错

4#
发表于 2011-3-5 22:25:18 | 只看该作者
羟乙基淀粉是现在术中特别好的液体!此消息究竟可靠与否

友情提示:转载请注意注明作者和出处!!

回复 支持 反对

使用道具 举报/纠错

5#
发表于 2011-3-5 22:27:17 | 只看该作者
真的假的啊!!
我们羟乙基用的很多啊

有奖活动:我为论坛出谋划策!! ←点击查看详情

回复 支持 反对

使用道具 举报/纠错

6#
 楼主| 发表于 2011-3-6 08:56:58 | 只看该作者
本帖最后由 华西小卒 于 2011-3-6 08:58 编辑

信息来源于英国的每日电讯报,提供详细的原始新闻链接,有空闲的战友请翻译下,对麻醉界战友息息相关的一个爆炸性新闻:
http://www.telegraph.co.uk/health/8360667/Millions-of-surgery-patients-at-risk-in-drug-research-fraud-scandal.html
Millions of surgery patients at risk in drug research fraud scandalMillions of NHS patients have been treated with controversial drugs on the basis of "fraudulent research" by one of the world's leading anaesthetists, The Daily Telegraph can disclose.

                               
登录/注册后可看大图

Guidelines for British anaesthetists regarding colloids are being revised after it emerged that four of the key studies on which they were based are to be formally retracted Photo: ALAMY
By Heidi Blake, Holly Watt and Robert Winnett 10:31PM GMT 03 Mar 2011

Comments

Joachim Boldt is at the centre of a criminal investigation amid allegations that he may have forged up to 90 crucial studies on the treatment. He has been stripped of his professorship and sacked from a German hospital following allegations about his research into drugs known as colloids.

Experts described Mr Boldt's alleged forgeries as possibly the biggest medical research scandal since Andrew Wakefield was struck off last year for falsely claiming to have proved a link between the MMR vaccine and autism.

Guidelines for British anaesthetists regarding colloids – used to boost blood volume in patients undergoing surgery – are being revised after it emerged that four of the key studies on which they were based are to be formally retracted.

Mr Boldt, 57, was regarded as a leading specialist in intravenous fluid management, and his work was published widely in British medical journals.

He claimed to have proved that colloids were as safe as other, similar treatments despite earlier studies showing them to be more dangerous. Mr Boldt's alleged forgeries date back up to a decade.
Related Articles



The Consensus Guidelines on Intravenous Fluid Therapy, published by six British medical groups including the Association of Surgeons and the Intensive Care Society, were being withdrawn last night. Prof John MacFie, president of the Association of Surgeons, suggested that some British patients could have been put in danger. He said he would urge other medics to abandon colloids.
"We have withdrawn the guidelines from our website and we will need to rewrite the article," he added. "The profession I represent does not want to be to be associated with potentially fraudulent research.
"Some people are comparing this to the Andrew Wakefield scandal. What Wakefield did had terrible implications on children's lives, and the principle of this is the same." As chief anaesthetist at Ludwigshafen Hospital in the Rhineland, Mr Boldt was the leading advocate of colloids, which are now commonly used across Europe.
He published dozens of papers "proving" their benefits and contradicting studies which suggested they could increase the risk of death in surgery and cause kidney failure, severe blood loss and heart failure.
German medical authorities are scrutinising 92 of his key publications and a criminal investigation is under way into allegations that he forged documents, tested drugs on patients without their consent and fraudulently claimed payments for operations he had never performed.
Mr Boldt received funding from manufacturers of hydroxyethyl starch (HES) – the colloid he most strongly advocated – including B. Braun, Baxter and Fresenius Kabi.
He was frequently paid to speak at international medical conferences where he hailed HES as "the holy grail" of fluid drugs.
HES and other colloids are up to 10 times more expensive than the alternative fluid management drugs, crystalloids, which some experts believe are safer as they contain smaller molecules and are more easily absorbed. Mr Boldt was sacked from Ludwigshafen Hospital last November. It has established an investigating commission to review 29 of the 92 papers which have been identified as "highly suspected" of containing forged or distorted data. The others will be examined if serious evidence of forgery is found.
Prof Eike Martin, head of the investigating commission, told The Telegraph: "At first we thought that all the studies were 100 per cent invented, but now we have found a huge amount of clinical data from trials that were conducted.
"Our suspicion is that the trials are not reported accurately in the papers. Prof Boldt was an advocate for colloids and that was the conclusion of his studies, but the data he published is different from the original data we have seen.”
Prof Martin said investigators examining one study, which purported to show that HES caused less inflammation than another fluid management drug, had found that the original data contradicted the conclusion.
The editors in chief of a consortium of medical journals which published Mr Boldt’s work are also reviewing the 92 publications.
Sources close to the investigation said that the editors would announce the formal retraction of 89 papers next month.
Rhineland state prosecutors are investigating Mr Boldt over allegations that he forged the signatures of his alleged “co-authors” on his studies, conducted drugs trials without official approval and claimed money for operations that he never performed. Police raided his home and his offices at the hospital in December and seized paperwork and computers.
Lothar Liebig, the state’s director of public prosecutions, said: “Boldt
published certain studies about medical drugs in order to get them accepted.
“There there is a strong suspicion that he deliberately failed to obtain the approval of the institutional review board in Ludwigshafen, which is a criminal offence.”
Other medical research has contradicted Mr Boldt’s findings.
Research by Dr Gill Schierhout and Dr Ian Roberts of University College London found in 1998 that the use of colloids during surgery increased the risk of death by four percentage points – equivalent to four extra deaths in every 100 patients.
A review published 10 years later by Konrad Reinhart and Christiane Hartog of Friedrich Schiller University in Jena, Germany cited two large-scale clinical trials which found that HES could prevent the blood from clotting, which can cause heavy bleeding. Other studies have shown that some colloids can result in complications including heart and kidney failure, fluid entering the lungs and anaphylactic shock.
Suspicion first fell on Mr Boldt in October when readers of an article that he had published in the US journal Anesthesia and Analgesia, about the benefits of HES in bypass surgery, noticed that the pattern shown by his data was “too perfect to be believed”.
Dr Rupert Pearse, a senior lecturer in intensive care medicine at Barts and the London School of Medicine, and co-author of the British guidelines on fluid drugs, said last night: “I specifically remember looking at a paper of his last year and being surprised at how lucky he had been with his results.
“For me, it shakes the world I work in and makes me feel less confident in it, and if I were a member of the public I would feel the same.”
Mr Boldt was unavailable for comment.

论坛公告:2013年论坛版主火热招聘中!! (←点击查看详情

回复 支持 反对

使用道具 举报/纠错

您需要登录后才可以回帖 登录 | 会员注册

本版积分规则


论坛郑重声明 本站供网上自由讨论使用,所有个人言论并不代表本站立场,所发布资源均来源于网络,假若內容有涉及侵权,请联络我们。我们将立刻删除侵权资源,并向版权所有者致以诚挚的歉意!
收藏帖子 返回列表 联系我们 搜索 官方QQ群

QQ|关于我们|业务合作|手机版|新青年麻醉论坛 ( 浙ICP备19050841号-1 )

GMT+8, 2025-4-5 03:10 , Processed in 0.163231 second(s), 23 queries , Gzip On.

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表